Close Menu

NEW YORK (GenomeWeb) – Danaher today announced a 5 percent year-over-year increase in its fourth quarter revenues, beating the consensus Wall Street estimate.

For the three months ended Dec. 31, 2018, the Washington-based conglomerate posted $5.36 billion in revenues, up from $5.09 billion in Q4 2017. Wall Street had expected, on average, revenues of $5.32 billion.

Non-GAAP core revenues were up almost 6 percent year over year, Danaher said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.